Tower Research Capital LLC (Trc) Karuna Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$161.01 - $317.85 $189,347 - $373,791	-1,176 Reduced 77.88%	334 $105,000
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $92,374 - $122,342	-561 Reduced 27.09%	1,510 $255,000
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $23,097 - $31,468	131 Added 6.75%	2,071 $449,000
Q1 2023 May 09, 2023	BUY	$161.33 - $204.36 $107,768 - $136,512	668 Added 52.52%	1,940 $352,000
Q4 2022 Feb 10, 2023	SELL	$191.53 - $236.82 $1.29 Million - $1.6 Million	-6,755 Reduced 84.15%	1,272 $250,000

Q3 2022 Nov 10, 2022	BUY	$123.79 - $277.42 $621,178 - $1.39 Million	5,018 Added 166.77%	8,027 $1.81 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $207,861 - $317,045	2,212 Added 277.54%	3,009 $381,000
Q1 2022 May 12, 2022	SELL	$98.9 - $132.37 $222,722 - $298,097	-2,252 Reduced 73.86%	797 $101,000
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $169,279 - $243,882	1,530 Added 100.72%	3,049 $399,000
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $133,887 - $166,526	-1,323 Reduced 46.55%	1,519 $186,000
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $224,355 - $283,863	2,088 Added 276.92%	2,842 $324,000
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $61,380 - $85,570	-643 Reduced 46.03%	754 $91,000
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $39,646 - $57,564	527 Added 60.57%	1,397 $142,000
Q3 2020 Nov 16, 2020	SELL	$71.31 - $109.74 $305,563 - $470,235	-4,285 Reduced 83.12%	870 $67,000
Q2 2020 Aug 13, 2020	BUY	$62.14 - $117.21 $320,331 - $604,217	5,155 New	5,155 $575,000

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.